Your session is about to expire
← Back to Search
Speculum-Free Screening Device for Cervical Cancer (Calla Trial)
Calla Trial Summary
This trial will use optical technologies to determine the optical signatures of cervical dysplasia.
Calla Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCalla Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Calla Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a healthy woman.I am between 21 and 65 years old.I have had a pelvic exam.
- Group 1: Healthy Volunteers
- Group 2: Patient surveillance
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research opportunity remain accessible to participants?
"Indeed, the evidence on clinicaltrials.gov suggests that this medical experiment is actively seeking participants. It was initially posted April 14th 2016 and recently revised June 24th 2022; 305 individuals are required to be recruited from 1 site."
May individuals below the age of fifty participate in this research?
"This research requires the enrolment of patients who are within 21 to 65 years old."
Who has the necessary qualifications to participate in this investigation?
"To qualify for the study, potential participants should have uterine cervical neoplasms and lie within the designated age range of 21-65. A total of 305 candidates are expected to be enrolled in this trial."
How many individuals are involved in this research endeavor?
"Affirmative. Clinicaltrials.gov has the relevant information, which shows that this medical trial was initially posted on April 14th 2016 and last edited on June 24th 2022. This initiative is currently seeking 305 patients from a single location."
Share this study with friends
Copy Link
Messenger